(Q50523195)

English

β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts.

scientific article published on 4 November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22057701

β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22057701

Escherichia coli

0 references

Jesús Rodríguez-Baño

1

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22057701

author name string

María Dolores Navarro

2

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22057701

Pilar Retamar

3

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22057701

Encarnación Picón

4

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22057701

Álvaro Pascual

5

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22057701

Extended-Spectrum Beta-Lactamases–Red Española de Investigación en Patología Infecciosa/Grupo de Estudio de Infección Hospitalaria Group

6

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22057701

language of work or name

0 references

publication date

4 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22057701

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22057701

54

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22057701

2

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22057701

167-174

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22057701

Extended-spectrum beta-lactamases: a clinical update

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Clinical significance of extended-spectrum beta-lactamases.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Antimicrobial susceptibility of intra-abdominal gram-negative bacilli from Europe: SMART Europe 2008.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in the United States, 2007-2008: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART).

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Diversity of Escherichia coli strains producing extended-spectrum beta-lactamases in Spain: second nationwide study

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases in Spain: microbiological and clinical features

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isola

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

In vivo efficacies of beta-lactam-beta-lactamase inhibitor combinations against a TEM-26-producing strain of Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Predictors of mortality from community-onset bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Clinical outcome of empiric antimicrobial therapy of bacteremia due to extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Bacteremia due to extended-spectrum-beta-lactamase-producing Enterobacter cloacae: role of carbapenem therapy

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Breakpoints for extended-spectrum beta-lactamase-producing Enterobacteriacae: pharmacokinetic/pharmacodynamic considerations

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Pharmacokinetics-Pharmacodynamics of Cefepime and Piperacillin- Tazobactam against Escherichia coli and Klebsiella pneumoniae Strains Producing Extended-Spectrum β-Lactamases: Report from the ARREST Program

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Extended-spectrum and CMY-type b-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR790

21 January 2018

Identifiers

10.1093/CID/CIR790

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22057701

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22057701

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50523195&oldid=1233298763"